StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bristol-Myers Squibb Co. (BMY) PT Raised to $57 at BMO Capital
July 27, 2018 8:21 AM
BMO Capital raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $57.00 (from $51.00) while maintaining a Market ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Bristol-Myers Squibb (BMY) Reports EMA Approval for Opdivo (nivolumab)
July 31, 2018 7:00 AM
Bristol-Myers Squibb Co. (BMY) PT Raised to $63 at Morgan Stanley
July 27, 2018 7:37 AM
Merck profit beats, but Keytruda sales fail to impress
July 27, 2018 6:57 AM
Amgen profit beats Street view, will not raise prices again in 2018
July 26, 2018 4:16 PM
Bristol-Myers Squibb (BMY) Tops Q2 EPS by 14c; Raises Outlook
July 26, 2018 7:01 AM
Bristol-Myers Squibb Reports Second Quarter Financial Results
July 26, 2018 6:59 AM
